These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16494512)

  • 1. ACE inhibitors in pediatric patients with heart failure.
    Momma K
    Paediatr Drugs; 2006; 8(1):55-69. PubMed ID: 16494512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulatory failure in children with left-to-right shunt in the framework of congenital heart defects: pathophysiology and therapeutic results].
    Wessel A; Buchhorn R; Bürsch J
    Klin Padiatr; 2000; 212(2):53-9. PubMed ID: 10812553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE inhibitors in heart failure: an update.
    Smith WH; Ball SG
    Basic Res Cardiol; 2000; 95 Suppl 1():I8-14. PubMed ID: 11192359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors: a comparative review.
    Raia JJ; Barone JA; Byerly WG; Lacy CR
    DICP; 1990 May; 24(5):506-25. PubMed ID: 2188439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibitors in heart failure: what more do we need to know?
    Demers C; Mody A; Teo KK; McKelvie RS
    Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.
    Langtry HD; Markham A
    Drugs Aging; 1997 Feb; 10(2):131-66. PubMed ID: 9061270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.
    Song JC; White CM
    Clin Pharmacokinet; 2002; 41(3):207-24. PubMed ID: 11929321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of heart failure--an overview.
    Erdmann E
    Basic Res Cardiol; 2000; 95 Suppl 1():I3-7. PubMed ID: 11192349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: role of angiotensin-converting enzyme inhibitor therapy.
    Pisacane C; Pacileo G; Santoro G; Sarubbi B; Iacono C; Russo MG; Calabrò R
    Ital Heart J; 2001 Feb; 2(2):100-6. PubMed ID: 11256536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitors in heart failure: prospects and limitations.
    Pitt B
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():285-90. PubMed ID: 9211022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of chronic heart failure in children.
    Ross RD
    Am J Cardiovasc Drugs; 2001; 1(1):37-44. PubMed ID: 14728050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitors in the treatment of heart failure.
    DiBianco R
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII32-8. PubMed ID: 2189619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
    Kiowski W; Beermann J; Rickenbacher P; Haemmerli R; Thomas M; Burkart F; Meinertz T
    Circulation; 1994 Dec; 90(6):2748-56. PubMed ID: 7994817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure.
    Dékány M; Bányai F; Antalóczy Z
    Acta Physiol Hung; 1988; 72 Suppl():93-110. PubMed ID: 3075406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
    Schön HR
    J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.